BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1648228)

  • 1. Mutagenesis of the myogenin basic region identifies an ancient protein motif critical for activation of myogenesis.
    Brennan TJ; Chakraborty T; Olson EN
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5675-9. PubMed ID: 1648228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The basic region of myogenin cooperates with two transcription activation domains to induce muscle-specific transcription.
    Schwarz JJ; Chakraborty T; Martin J; Zhou JM; Olson EN
    Mol Cell Biol; 1992 Jan; 12(1):266-75. PubMed ID: 1309591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.
    Chakraborty T; Brennan TJ; Li L; Edmondson D; Olson EN
    Mol Cell Biol; 1991 Jul; 11(7):3633-41. PubMed ID: 1646392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12.
    Davis RL; Weintraub H
    Science; 1992 May; 256(5059):1027-30. PubMed ID: 1317057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
    Olson E
    Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimers of myogenic helix-loop-helix regulatory factors and E12 bind a complex element governing myogenic induction of the avian cardiac alpha-actin promoter.
    French BA; Chow KL; Olson EN; Schwartz RJ
    Mol Cell Biol; 1991 May; 11(5):2439-50. PubMed ID: 1850096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins.
    Taylor DA; Kraus VB; Schwarz JJ; Olson EN; Kraus WE
    Mol Cell Biol; 1993 Aug; 13(8):4714-27. PubMed ID: 8393137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyoD and achaete-scute: 4-5 amino acids distinguishes myogenesis from neurogenesis.
    Davis RL; Cheng PF; Lassar AB; Thayer M; Tapscott S; Weintraub H
    Princess Takamatsu Symp; 1989; 20():267-78. PubMed ID: 2562185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4.
    Chakraborty T; Olson EN
    Mol Cell Biol; 1991 Dec; 11(12):6103-8. PubMed ID: 1658626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium butyrate inhibits myogenesis by interfering with the transcriptional activation function of MyoD and myogenin.
    Johnston LA; Tapscott SJ; Eisen H
    Mol Cell Biol; 1992 Nov; 12(11):5123-30. PubMed ID: 1328872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression.
    Li L; Chambard JC; Karin M; Olson EN
    Genes Dev; 1992 Apr; 6(4):676-89. PubMed ID: 1313772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA binding and transcriptional regulatory activity of mammalian achaete-scute homologous (MASH) proteins revealed by interaction with a muscle-specific enhancer.
    Johnson JE; Birren SJ; Saito T; Anderson DJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3596-600. PubMed ID: 1314394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4.
    Valdez MR; Richardson JA; Klein WH; Olson EN
    Dev Biol; 2000 Mar; 219(2):287-98. PubMed ID: 10694423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myogenin's functions do not overlap with those of MyoD or Myf-5 during mouse embryogenesis.
    Rawls A; Morris JH; Rudnicki M; Braun T; Arnold HH; Klein WH; Olson EN
    Dev Biol; 1995 Nov; 172(1):37-50. PubMed ID: 7589813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of myogenin function by TGF-beta 1 is targeted at the basic helix-loop-helix motif and is independent of E2A products.
    Martin JF; Li L; Olson EN
    J Biol Chem; 1992 Jun; 267(16):10956-60. PubMed ID: 1317849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.
    Bergstrom DA; Tapscott SJ
    Mol Cell Biol; 2001 Apr; 21(7):2404-12. PubMed ID: 11259589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.
    Wright WE; Sassoon DA; Lin VK
    Cell; 1989 Feb; 56(4):607-17. PubMed ID: 2537150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor.
    Funk WD; Wright WE
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9484-8. PubMed ID: 1329097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyoR: a muscle-restricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD.
    Lu J; Webb R; Richardson JA; Olson EN
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):552-7. PubMed ID: 9892671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins.
    Li L; Heller-Harrison R; Czech M; Olson EN
    Mol Cell Biol; 1992 Oct; 12(10):4478-85. PubMed ID: 1328856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.